Skip to main content
SpringerLink
Log in

Antiepileptika

  • Chapter
Arzneiverordnungs- Report 2014

Zusammenfassung

Auffällig ist das kontinuierlich steigende Verordnungsvolumen der neueren Antiepileptika, die inzwischen fast doppelt so häufig wie traditionelle Antiepileptika (z. B. Valproinsäure, Carbamazepin, Phenytoin) verordnet werden. Das früher führende Carbamazepin hat in den letzten 10 Jahren um fast 40% abgenommen. Die Verordnungen von Valproinsäure stagnieren. Levetiracetam ist 2013 zu dem führenden Antiepileptikum aufgestiegen. Weitere häufig verordnete Vertreter der neueren Antiepileptika sind Lamotrigin, Gabapentin und Pregabalin.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, et al. for the Gabapentin Diabetic Neuropathy Study Group (1998): Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA 280: 1831–1836

    Google Scholar 

  • Ben-Menachem E, Biton V, Jatuzis D, Abou-Khalil B, Doty P, Rudd GD (2007): Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 48: 1308–1317

    PubMed  Google Scholar 

  • Beydoun A (1999): Monotherapy trials with gabapentin for partial epilepsy. Epilepsia 40 (Suppl 6): S1–3–S16

    Google Scholar 

  • Boyle J, Eriksson ME, Gribble L, Gouni R, Johnsen S, Coppini DV, Kerr D (2012): Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life. Diabetes Care 35: 2451–2458

    Article  PubMed Central  PubMed  Google Scholar 

  • Brodie MJ (2004): Pregabalin as adjunctive therapy for partial seizures. Epilepsia 45 Suppl 6: 19–27

    PubMed  Google Scholar 

  • Brodie MJ, Perucca E, Ryvlin P, Ben-Menachem E, Meencke HJ (2007): Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 68: 402–408

    Article  PubMed  Google Scholar 

  • Bundesministerium für Gesundheit (2013): Bekanntmachung eines Beschlusses des Gemeinsamen Bundesausschusses über eine Änderung der Arzneimittel-Richtlinie (AM-RL): Anlage XII – Beschlüsse über die Nutzenbewertung von Arzneimitteln mit neuen Wirkstoffen nach § 35a des Fünften Buches Sozialgesetzbuch (SGB V) Perampanel vom 7. März 2013 veröffentlicht 7. März 2013, BAnz AT 26.03.2013 B–4

    Google Scholar 

  • Carmichael K, Pulman J, Lakhan SE, Parikh P, Marson AG (2013): Zonisamide add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev. 2013 Dec 19; 12: CD001416

    Google Scholar 

  • Costa J, Fareleira F, Ascenção R, Borges M, Sampaio C, Vaz-Carneiro A (2011): Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: a systematic review and meta-analysis. Epilepsia 52: 1280–1291

    Google Scholar 

  • Devinsky O (2011): Sudden, unexpected death in epilepsy. N Engl J Med 365: 1801–1811

    Article  PubMed  Google Scholar 

  • Dooley M, Plosker GL (2000): Levetiracetam. A review of its adjunctive use in the management of partial onset seizures. Drugs 60: 871–893

    PubMed  Google Scholar 

  • Eisai (2013): Eisai setzt vorübergehend den Vertrieb des innovativen Antiepileptikums Fycompa ® (Perampanel) in Deutschland aus. Internet: http://www.presseportal.de/pm/64962/2500257/

  • European Medicines Agency (2004): Europäischer öffentlicher Beurteilungsbericht (EPAR) Lyrica. Scizentific discussion. Internet: www.emea.europa.eu/humandocs/PDFs/EPAR/lyrica/084504en6.pdf

  • French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE Jr, Sachdeo RC, Beydoun A, Glauser TA; American Academy of Neurology Therapeutics and Technology Assessment Subcommittee; American Academy of Neurology Quality Standards Subcommittee; American Epilepsy Society Quality Standards Subcommittee; American Epilepsy Society Therapeutics and Technology Assessment Subcommittee (2004): Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 45: 401–409

    Google Scholar 

  • Gamble CL, Williamson PR, Marson AG (2006): Lamotrigine versus carbamazepine monotherapy for epilepsy. Cochrane Database Syst Rev 25 (1):CD00103–1

    Google Scholar 

  • Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, Kalviainen R, Mattson R, Perucca E, Tomson T (2006): ILAE Treatment Guidelines: Evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 47: 1094–1120

    Article  Google Scholar 

  • Goa KL, Ross SR, Chrisp P (1993): Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy. Drugs 46: 152–176

    PubMed  Google Scholar 

  • Hitiris N, Brodie MJ (2006): Modern antiepileptic drugs: guidelines and beyond. Curr Opin Neurol 19: 175–180

    PubMed  Google Scholar 

  • Holmes D (2012): NICE epilepsy guidance „may be detrimental to patient care“. Lancet 379: 39–9

    Article  Google Scholar 

  • Kassenärztliche Bundesvereinigung (2007): Wirkstoff AKTUELL. Pregabalin (Lyrica® Hartkapseln). Internet: www.kbv.de/publikationen/116.html

  • Koch MW, Polman SK (2009): Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures. Cochrane Database Syst Rev. 2009 Oct 7; (4):CD00645–3

    Google Scholar 

  • Kwan P, Sander JW (2004): The natural history of epilepsy: an epidemiological view. J Neurol Neurosurg Psychiatry 75: 1376–1381

    Article  PubMed Central  PubMed  Google Scholar 

  • LaRoche SM, Helmers SL (2004): The new antiepileptic drugs: scientific review. JAMA 291: 605–614

    Google Scholar 

  • Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B (2004): The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. PNAS 101: 9861–9866

    Google Scholar 

  • Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJL, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DS, Smith PEM, Tudor Smith C, Vanoli A, Williamson PR, on behalf of the SANAD Study group (2007a): The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 369: 1000–1015

    Google Scholar 

  • Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJL, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DS, Smith PEM, Tudor Smith C, Vanoli A, Williamson PR, on behalf of the SANAD Study group (2007b): The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalized and unclassifiable epilepsy: an unblinded randomized controlled trial. Lancet 369: 1016–1026

    Google Scholar 

  • Mbizvo GK, Dixon P, Hutton JL, Marson AG (2012): Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review. Cochrane Database Syst Rev. 2012 Sep 12; 9: CD00190–1

    Google Scholar 

  • McCorry D, Chadwick D, Marson A (2004): Current drug treatment of epilepsy in adults. Lancet Neurol 3: 729–735

    Article  PubMed  Google Scholar 

  • Milburn-McNulty P, Powell G, Sills GJ, Marson AG (2014): Sulthiame monotherapy for epilepsy. Cochrane Database Syst Rev. 2014 Mar 9; 3: CD01006–2

    Google Scholar 

  • Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ (2009): Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev. 2009 Jul 8; (3): CD00707–6

    Google Scholar 

  • Morello CM, Leckband SG, Stoner CP, Moorhouse DF, Sahagian GA (1999): Randomized double- blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 159: 1931–1937

    Article  PubMed  Google Scholar 

  • National Institute for Health and Clinical Excellence (NICE) (2012): The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. January 2012, NICE clinical guideline 137. Internet: www.nice.org.uk/page.aspx- ? o=CG020NICEguideline

    Google Scholar 

  • Nunes VD, Sawyer L, Neilson J, Sarri G, Cross JH (2013): Profile of lacosamide and its role in the long-term treatment of epilepsy: a perspective from the updated NICE guideline. Neuropsychiatr Dis Treat 9: 467–476

    PubMed Central  PubMed  Google Scholar 

  • Perucca E, Yasothan U, Clincke G, Kirkpatrick P (2008): Lacosamide. Nat Rev Drug Discov 7: 973–974

    Article  PubMed  Google Scholar 

  • Pulman J, Jette N, Dykeman J, Hemming K, Hutton JL, Marson AG (2014): Topiramate add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev. 2014 Feb 25; 2: CD00141–7

    Google Scholar 

  • Shorvon SD (2009): Drug treatment of epilepsy in the century of the ILAE: the second 50 years, 1959–2009. Epilepsia 50 Suppl 3: 93–130

    PubMed  Google Scholar 

  • Steinhoff BJ (2014): Efficacy of perampanel: a review of pooled data. Epilepsia 55 Suppl 1: 9–12

    Google Scholar 

  • Tomson T, Battino D (2012): Teratogenic effects of antiepileptic drugs. Lancet Neurol 11: 803–813

    Google Scholar 

Download references

Author information

Authors and Affiliations

    Authors
    1. Prof. Dr. med. Ulrich Schwabe
      View author publications

      You can also search for this author in PubMed Google Scholar

    Editor information

    Editors and Affiliations

    1. Pharmakologisches Institut, Universität Heidelberg, Im Neuenheimer Feld 366, 69120, Heidelberg

      Ulrich Schwabe

    2. Bachstraße 29, 50858, Köln

      Dieter Paffrath

    Rights and permissions

    Reprints and permissions

    Copyright information

    © 2014 Springer-Verlag Berlin Heidelberg

    About this chapter

    Cite this chapter

    Schwabe, U. (2014). Antiepileptika. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs- Report 2014. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43487-1_13

    Download citation

    • DOI: https://doi.org/10.1007/978-3-662-43487-1_13

    • Publisher Name: Springer, Berlin, Heidelberg

    • Print ISBN: 978-3-662-43486-4

    • Online ISBN: 978-3-662-43487-1

    • eBook Packages: Medicine (German Language)

    Publish with us

    Policies and ethics

    Search

    Navigation